Cargando…

Pseudothrombocytopenia in a patient with bipolar type 2 disorder on lurasidone: A case report

Detalles Bibliográficos
Autores principales:	Sakhardande, Kasturi Atmaram, Sharma, Lavanya P., Arumugham, Shyam Sundar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992749/ https://www.ncbi.nlm.nih.gov/pubmed/35400743 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_625_21

Ejemplares similares

Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia, presenting as spurious pancytopenia, associated with risperidone
por: Mamtani, Harkishan, et al.
Publicado: (2023)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
por: Kemper, Marcel, et al.
Publicado: (2021)

Ethylene diamine tetra aceticacid pseudothrombocytopenia: A must to know entity for Anaesthesiologists
por: Sudha, P, et al.
Publicado: (2013)

Lurasidone-induced Oculogyric Crisis
por: Das, Soumitra, et al.
Publicado: (2017)

Lurasidone-induced Parkinsonism and Hyperprolactinemia
por: Suthar, Navratan, et al.
Publicado: (2019)

TULIP study: Trail of Lurasidone in bipolar disorder in Pakistan()
por: Khan, Nasar, et al.
Publicado: (2021)

Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report
por: Siwek, Marcin, et al.
Publicado: (2021)

A Case Report of Sinus Bradycardia after the Addition of Lurasidone in a Patient with Bipolar Disorder
por: Kuang, Qijie, et al.
Publicado: (2023)

Severe Extrapyramidal Syndrome Caused by Lurasidone Low Dose
por: Das, Soumitra, et al.
Publicado: (2018)

First-rank symptoms in Bipolar disorder: A case report
por: Sharma, Markanday, et al.
Publicado: (2021)

Pseudothrombocytopenia--a cautionary tale.
por: Kettle, P., et al.
Publicado: (1991)

Mild Decrease in Blood Glucose Levels May Predict Efficacy of Antipsychotic Lurasidone
por: Nagamine, Takahiko, et al.
Publicado: (2023)

Lurasidone for the treatment of bipolar depression: an evidence-based review
por: Franklin, Rachel, et al.
Publicado: (2015)

Management of bipolar I depression: clinical utility of lurasidone
por: Findlay, Lillian Jan, et al.
Publicado: (2015)

COVID‐19‐associated pseudothrombocytopenia
por: Van Dijck, Ruben, et al.
Publicado: (2021)

Catatonia in a patient with bipolar disorder type I
por: Muneer, Ather
Publicado: (2014)

Neurocognitive Deficits in Recently Diagnosed Young Remitted Bipolar I Disorder and At-Risk Subjects: Potential Endophenotypes?
por: Reddy, Preethi V., et al.
Publicado: (2023)

Concurrent catatonia and COVID-19 infection – An experiential account of challenges and management of cases from a tertiary care psychiatric hospital in India
por: Sakhardande, Kasturi Atmaram, et al.
Publicado: (2022)

Polarity Index: A Novel Bipolar Metric: Is it Clinically Useful?
por: Gnanavel, Sundar
Publicado: (2015)

Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews
por: Fornaro, Michele, et al.
Publicado: (2017)

Oxcarbazepine – induced hyponatremia in bipolar disorder: A report of two cases
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2016)

EDTA-dependent Pseudothrombocytopenia Confirmed by Supplementation of Kanamycin; A Case Report
por: Ahn, Hae Lyun, et al.
Publicado: (2002)

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)

Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023)

Can Pseudothrombocytopenia be recognised at first look?
por: Yilmaz, Seda, et al.
Publicado: (2023)

Gastaut-Geschwind Syndrome in a Patient of Bipolar Disorder: A Case Report
por: Mudgal, Varchasvi, et al.
Publicado: (2021)

A Curious Case of Pseudothrombocytopenia due to In Vitro Agglutination
por: Zhong, Le, et al.
Publicado: (2020)

Successful treatment of bipolar disorder by resection of lung tumor: A case report
por: Chao, Pei-Chun, et al.
Publicado: (2018)

Pseudothrombocytopenia by ethylenediaminetetraacetic acid can jeopardize patient safety – report
por: Abal, Cristina Collazo, et al.
Publicado: (2020)

Pseudothrombocytopenia due to Platelet Clumping: A Case Report and Brief Review of the Literature
por: Tan, Geok Chin, et al.
Publicado: (2016)

Pseudothrombocytopenia with multiple anticoagulant sample collection tubes
por: Kovacs, Ferenc, et al.
Publicado: (2016)

In-Hospital Onset of Pseudothrombocytopenia Days before Surgery
por: Souza, Luiz, et al.
Publicado: (2018)

Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment
por: Pikalov, Andrei, et al.
Publicado: (2017)

LURASIDONE IN THE LONG‐TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24‐WEEK OPEN‐LABEL EXTENSION STUDY
por: Ketter, Terence A., et al.
Publicado: (2016)

Pseudothrombocytopenia in perioperative patient: A significant laboratory artifact
por: Senthilkumaran, Subramanian, et al.
Publicado: (2013)

Pseudothrombocytopenia—A Review on Causes, Occurrence and Clinical Implications
por: Lardinois, Benjamin, et al.
Publicado: (2021)

Lurasidone-induced mania: A case report
por: Fernández, T., et al.
Publicado: (2022)

Prepubertal bipolar disorder: a diagnostic quandary?
por: Malhi, Gin S., et al.
Publicado: (2020)

Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression
por: Singh, Manpreet K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1o2afpcmo5t52nl0in8kiv7pk1